| Terry Mark Himes, DO | |
|
2651 E Discovery Pkwy, Bloomington, IN 47408-9059 | |
| (812) 353-5222 | |
| (812) 353-5262 |
| Full Name | Terry Mark Himes |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 41 Years |
| Location | 2651 E Discovery Pkwy, Bloomington, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700995438 | NPI | - | NPPES |
| 71288333 -INDIVIDUAL | Medicaid | CO | |
| 10024983100 | Medicaid | NE | |
| 41631 | Other | CO | COLORADO STATE LICENSE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi-st Vincent Infirmary | Little rock, AR | Hospital |
| Chi Health St. Francis | Grand island, NE | Hospital |
| Chi Health Good Samaritan | Kearney, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Veeone Medical Group Pa | 6800262437 | 21 |
| Veeone Medical Group Pa | 6800262437 | 21 |
| Veeone Medical Group Pa | 6800262437 | 21 |
| Multicare Health System | 7719899897 | 1704 |
| St Vincent Medical Group | 5698758803 | 139 |
News Archive
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
With the advancement of technology and medicine, G. Michael Deeb, M.D., a cardiac surgeon at Michigan Medicine, says society is used to, and expects, instant solutions to their pain after medical procedures. This has resulted in an increased demand for narcotics, as well as their over usage.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University
› Verified 5 days ago
| Entity Name | Cherry County Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033218037 PECOS PAC ID: 5698686012 Enrollment ID: O20040505000487 |
News Archive
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
With the advancement of technology and medicine, G. Michael Deeb, M.D., a cardiac surgeon at Michigan Medicine, says society is used to, and expects, instant solutions to their pain after medical procedures. This has resulted in an increased demand for narcotics, as well as their over usage.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University
› Verified 5 days ago
| Entity Name | Veeone Medical Group Texas Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477199321 PECOS PAC ID: 4385044452 Enrollment ID: O20220610001789 |
News Archive
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
With the advancement of technology and medicine, G. Michael Deeb, M.D., a cardiac surgeon at Michigan Medicine, says society is used to, and expects, instant solutions to their pain after medical procedures. This has resulted in an increased demand for narcotics, as well as their over usage.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University
› Verified 5 days ago
| Entity Name | Veeone Medical Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265156558 PECOS PAC ID: 6800262437 Enrollment ID: O20221201001456 |
News Archive
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
With the advancement of technology and medicine, G. Michael Deeb, M.D., a cardiac surgeon at Michigan Medicine, says society is used to, and expects, instant solutions to their pain after medical procedures. This has resulted in an increased demand for narcotics, as well as their over usage.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Terry Mark Himes, DO 250 N Shadeland Ave, Indianapolis, IN 46219-4959 Ph: () - | Terry Mark Himes, DO 2651 E Discovery Pkwy, Bloomington, IN 47408-9059 Ph: (812) 353-5222 |
News Archive
Johnson & Johnson Pharmaceutical Research and Development (J&JPRD) announced that the U.S. Food and Drug Administration (FDA) has approved a new drug application (NDA) for PANCREAZE™ (pancrelipase) delayed-release capsules for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis or other conditions. Exocrine pancreatic insufficiency is the inability to properly digest and absorb food due to a lack of enzymes made by the pancreas that are important in the digestion of fats, proteins, and sugars.
Targeting the neuroinflammatory causes of Parkinson's disease with a naturally present brain chemical signal could offer a better understanding of the clinical mechanisms of the disease and open a future therapeutic window, reports a team of researchers from the University of South Florida Department Neurosurgery and Brain Repair and the James A. Haley Veterans' Administration Hospital, Tampa.
With the advancement of technology and medicine, G. Michael Deeb, M.D., a cardiac surgeon at Michigan Medicine, says society is used to, and expects, instant solutions to their pain after medical procedures. This has resulted in an increased demand for narcotics, as well as their over usage.
Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, today announced the Company's oncology drug candidate, CF102, has been granted Orphan Drug Designation by the European Medicines Agency (EMA) for the indication of hepatocellular carcinoma (HCC), the most common form of liver cancer.
Protein expression of the tumor suppressing gene Rb2/p130 could play a vital role in ovarian cancer, according to a study by researchers at the Sbarro Institute for Cancer Research and Molecular Medicine in the Center for Biotechnology at Temple University
› Verified 5 days ago
Jonathan Wicks, ATC, LAT, M.ED Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1001 E 17th St, Bloomington, IN 47408 Phone: 812-855-7920 | |
Dr. James G Marencik, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 645 S Rogers St, Bloomington, IN 47403 Phone: 812-339-1691 Fax: 812-339-8109 | |
Dr. David Austin Duncan, DO Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-5630 Fax: 812-353-5441 | |
Alvin Perry Griffith, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 601 W 2nd St, Bloomington, IN 47403 Phone: 812-353-5603 Fax: 812-353-3451 | |
Marina Bota, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 645 S Rogers St, Bloomington, IN 47403 Phone: 812-339-1691 | |
Abdulrahim Ismail, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2651 E Discovery Pkwy, Bloomington, IN 47408 Phone: 812-353-5222 Fax: 812-353-5262 | |
Joel Harold Griffith, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 645 S Rogers St, Bloomington, IN 47403 Phone: 812-339-1691 |